SLC6A8 and colorectal carcinoma: To validate the role of SLC6A8 in mediating VTN‐induced oncogenic effects and M2 polarization, we initially conducted knockdown experiments targeting SLC6A8 expression in CRC cells (Figure S8A, Supporting Information).